Sunday, November 8, 2026

USD/EUR Bullish Momentum With A 1% Jump In The Last 10 Sessions

USD/EUR Bullish Momentum With A 1% Jump In The Last 10 Sessions

(VIANEWS) - USD/EUR (USDEUR) has been up by 1.35% for the last 10 sessions. At 21:08 EST on Wednesday, 19 June, USD/EUR (USDEUR) is $0.93.

USD/EUR's yearly highs and lows, it's 4.882% up from its 52-week low and 2.8% down from its 52-week high.

Volatility

USD/EUR's last week, last month's, and last quarter's current intraday variation average was 0.10%, 0.05%, and 0.27%, respectively.

USD/EUR's highest amplitude of average volatility was 0.28% (last week), 0.28% (last month), and 0.27% (last quarter), respectively.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, USD/EUR's Forex is considered to be overbought (>=80).

News about

  • Eur/usd price analysis: holds below 1.0750 ahead of US retail sales data. According to FXStreet on Tuesday, 18 June, "The EUR/USD pair trades on a softer note near 1.0730 on Tuesday during the early European trading hours. ", " According to the 4-hour chart, EUR/USD keeps the bearish vibe unchanged as the major pair holds below the key 100-period Exponential Moving Average (EMA). "
  • Eur/usd price analysis: seems vulnerable while below 1.0800 confluence support breakpoint. According to FXStreet on Wednesday, 19 June, "The EUR/USD pair might then accelerate the fall towards the 1.0650-1.0640 support zone before dropping to the 1.0600 mark, or the YTD low touched in April. ", "The said handle should act as a key pivotal point, which if cleared decisively might prompt a short-covering rally and lift the EUR/USD pair towards the 1.0865-1.0870 supply zone en route to the 1.0900 round-figure mark."
  • According to FXStreet on Wednesday, 19 June, "The EUR/USD pair has continued to stabilize, but still seems to lackenough steam to meaningfully reboundgiven lingering political risk and fiscal concerns weighing on the common currency, ING FX strategists note.", "The eurozone calendar only includes a speech by the European Central Bank'sMarioCenteno today, and we still think the unstable risk environment and downside risks for peripheral bonds will keep EUR/USD capped in the near term."
  • Eur/usd escapes Wednesday’s holiday volatility trap, set for wait to meaningful data. According to FXStreet on Wednesday, 19 June, "The EUR/USD is currently facing resistance from the 200-hour Exponential Moving Average (EMA) at 1.0767, making it challenging for the currency pair to surpass the 1.0750 mark. ", "If this trend continues, the EUR/USD could experience a downside reversal, potentially leading to new lows for 2024, possibly falling below 1.0600."

More news about USD/EUR (USDEUR).

In this story · Knowledge Files

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Season: Regulatory Deadlines and Data Readouts Against Cost Discipline and Slipping Timelines
From late October 2026 to January 2027, mid-cap biotechs cluster pivotal data presentations (ESMO, AHA, AASLD), FDA decision dates (ivonescimab BLA on 2026-11-14, lorundrostat on 2026-12-22) and Q3 earnings. Alongside these, several companies are managing capital: lowering R&D and SG&A guidance, pushing clinical milestones into 2027, authorizing a $400M buyback, and pursuing a delisting. Late-stage programs in oncology, hepatitis delta, hypertension and women's health look near commercial inflection, while cost cuts and delays point to uneven balance-sheet strength.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,996
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,996 facts checked against source5,552 source documents archived
Query this data → isubstrate.com
USD/EUR Bullish Momentum With A 1% Jump In The Last 10 Sessions | Via News